ATE283368T1 - Für die glutamatabhängigen chloridkanäle kodierende dna - Google Patents

Für die glutamatabhängigen chloridkanäle kodierende dna

Info

Publication number
ATE283368T1
ATE283368T1 AT95920633T AT95920633T ATE283368T1 AT E283368 T1 ATE283368 T1 AT E283368T1 AT 95920633 T AT95920633 T AT 95920633T AT 95920633 T AT95920633 T AT 95920633T AT E283368 T1 ATE283368 T1 AT E283368T1
Authority
AT
Austria
Prior art keywords
host cells
glutamatate
chloride channels
recombinant host
dna coding
Prior art date
Application number
AT95920633T
Other languages
English (en)
Inventor
Doris F Cully
Joseph P Arena
Ken K Liu
Demetrios Vassilatis
Original Assignee
Merck & Co Inc
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Univ Columbia filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE283368T1 publication Critical patent/ATE283368T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95920633T 1994-05-25 1995-05-19 Für die glutamatabhängigen chloridkanäle kodierende dna ATE283368T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/249,112 US5527703A (en) 1994-05-25 1994-05-25 DNA encoding glutamate gated chloride channels
PCT/US1995/006556 WO1995032302A1 (en) 1994-05-25 1995-05-19 Dna encoding glutamate gated chloride channels

Publications (1)

Publication Number Publication Date
ATE283368T1 true ATE283368T1 (de) 2004-12-15

Family

ID=22942110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920633T ATE283368T1 (de) 1994-05-25 1995-05-19 Für die glutamatabhängigen chloridkanäle kodierende dna

Country Status (8)

Country Link
US (1) US5527703A (de)
EP (1) EP0760864B1 (de)
JP (1) JP3623798B2 (de)
AT (1) ATE283368T1 (de)
CA (1) CA2191063C (de)
DE (1) DE69533796T2 (de)
ES (1) ES2232822T3 (de)
WO (1) WO1995032302A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276662B1 (it) * 1995-04-04 1997-11-03 Uni Degli Studi Camerino Vaccini polinucleotidici
US5693492A (en) * 1995-05-05 1997-12-02 Merck & Co., Inc. DNA encoding glutamate gated chloride channels
US5854411A (en) * 1997-01-09 1998-12-29 Incyte Pharmaceuticals, Inc. Human chloride channel
US6358701B1 (en) 1997-08-11 2002-03-19 Merck & Co., Inc. DNA molecules encoding Ctenocephalides felis glutamate gated chloride channels
US6048692A (en) * 1997-10-07 2000-04-11 Motorola, Inc. Sensors for electrically sensing binding events for supported molecular receptors
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
US7033789B1 (en) 1999-10-22 2006-04-25 Merck & Co., Inc. DNA molecules encoding L-glutamate-gated chloride channels from Schistocerca americana
JP4769401B2 (ja) * 2000-03-02 2011-09-07 メルク・シャープ・エンド・ドーム・コーポレイション Drosophilamelanogaster中のリガンド依存性塩素イオンチャネルをコードするDNA分子
US7267964B2 (en) * 2000-03-31 2007-09-11 Merial Limited DNA molecules encoding ligand gated ion channels from Dermacentor variabilis
JP2004500119A (ja) * 2000-03-31 2004-01-08 メルク エンド カムパニー インコーポレーテッド デルマセンター・ヴァリァビリスgaba依存性塩素イオンチャンネル
US6329174B1 (en) 2000-06-13 2001-12-11 Aventis Cropscience Sa Nucleic acid encoding lepidoteran glutamate-gated chloride channel
WO2003093789A2 (en) * 2002-05-01 2003-11-13 Fmc Corporation Method for measuring ion channel activity
JP7097070B2 (ja) 2015-10-01 2022-07-07 ゴレイニ インコーポレイテッド クロライドチャネルの標的発現及びその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ240921A (en) * 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
US5385831A (en) * 1990-12-12 1995-01-31 Zymogenetics, Inc. Method for producing a mammalian G protein coupled glutamate receptor
WO1992019717A1 (en) * 1991-04-02 1992-11-12 Baylor College Of Medicine A high-affinity human glutamate/aspartate uptake system
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
WO1993007161A1 (en) * 1991-10-04 1993-04-15 Cornell Research Foundation, Inc. Molecular cloning and transformation of cyclodiene resistance
US5693492A (en) * 1995-05-05 1997-12-02 Merck & Co., Inc. DNA encoding glutamate gated chloride channels

Also Published As

Publication number Publication date
JPH10507064A (ja) 1998-07-14
DE69533796D1 (de) 2004-12-30
EP0760864B1 (de) 2004-11-24
US5527703A (en) 1996-06-18
CA2191063A1 (en) 1995-11-30
EP0760864A4 (de) 2000-02-02
DE69533796T2 (de) 2005-11-10
WO1995032302A1 (en) 1995-11-30
ES2232822T3 (es) 2005-06-01
JP3623798B2 (ja) 2005-02-23
EP0760864A1 (de) 1997-03-12
CA2191063C (en) 2010-07-20

Similar Documents

Publication Publication Date Title
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
ATE283368T1 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
ATE335085T1 (de) Adenoviren mit veränderten faserproteinen
IT1269989B (it) Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria
DE69535641D1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
ATE90966T1 (de) Expression von protein-c.
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69635899D1 (de) Polypeptid, das die differenzierung unterdrueckt
DE10075011I2 (de) Rezeptoren für Tumornekrosisfaktor-alpha und-beta.
DE68914582D1 (de) Endothelin-DNA und ihre Verwendung.
ATE170192T1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
DE3688900D1 (de) Expression von protein c.
DK0973794T3 (da) Netrinreceptorer
WO1997007135A3 (en) Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
EP0785716A4 (de) Als lerk6 bezeichnetes cytokin
DE60129688D1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
DE69433902D1 (de) Neuartige tyrosinkinase
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
DK199900825A (da) Klonede glucagon-lignende peptid-2-receptorer
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
KR950704352A (ko) 테라포시데 아포노펠마로부터의 칼슘 통로 차단 폴리펩티드(calcium channel blocking polypeptides from theraphosidae aphonopelma)
DE69739525D1 (de) Neuer cxc chemokinrezeptor aus maus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties